SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-292844
Filing Date
2018-10-04
Accepted
2018-10-04 09:16:35
Documents
4
Period of Report
2018-10-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d633224d8k.htm 8-K 19629
2 EX-99.1 d633224dex991.htm EX-99.1 14210
3 EX-99.2 d633224dex992.htm EX-99.2 22269
4 GRAPHIC g633224g32l22.jpg GRAPHIC 3598
  Complete submission text file 0001193125-18-292844.txt   62750
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38042 | Film No.: 181107010
SIC: 2834 Pharmaceutical Preparations